Smischney Nathan J, Seisa Mohamed O, Morrow Allison S, Ponce Oscar J, Wang Zhen, Alzuabi Muayad, Heise Katherine J, Murad Mohammad H
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
HEModynamic and AIRway Management Group, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Anesthesiol Res Pract. 2020 May 8;2020:9637412. doi: 10.1155/2020/9637412. eCollection 2020.
To evaluate the effectiveness of an admixture of ketamine and propofol on peri-induction hemodynamics during airway manipulation, we searched electronic databases of randomized controlled trials from January 1, 2000, to October 17, 2018. Trial screening, selection, and data extraction were done independently by two reviewers with outcomes pooled across included trials using the random-effects model. We included 10 randomized trials (722 patients, mean age of 53.99 years, 39.96% female). American Society of Anesthesiologists physical status was reported in 9 trials with classes I and II representing the majority. Ketamine/propofol admixture was associated with a nonsignificant increase in heart rate (weighted mean difference, 3.36 beats per minute (95% CI, -0.88, 7.60), = 88.6%), a statistically significant increase in systolic blood pressure (weighted mean difference, 9.67 mmHg (95% CI, 1.48, 17.86), = 87.2%), a nonsignificant increase in diastolic blood pressure (weighted mean difference, 2.18 mmHg (95% CI, -2.82, 7.19), = 73.1%), and a nonsignificant increase in mean arterial pressure (weighted mean difference, 3.28 mmHg (95% CI, -0.94, 7.49), = 69.9%) compared to other agents. The risk of bias was high and the certainty of evidence was low. In conclusion, among patients undergoing airway manipulation and needing sedation, the use of a ketamine/propofol admixture may be associated with better hemodynamics compared to nonketamine/propofol sedation. This trial is registered with CRD42019125725.
为评估氯胺酮与丙泊酚混合剂在气道操作期间诱导期血流动力学方面的效果,我们检索了2000年1月1日至2018年10月17日的随机对照试验电子数据库。试验筛选、选择和数据提取由两名审阅者独立完成,使用随机效应模型对纳入试验的结果进行汇总。我们纳入了10项随机试验(722例患者,平均年龄53.99岁,女性占39.96%)。9项试验报告了美国麻醉医师协会身体状况分级,其中I级和II级占大多数。与其他药物相比,氯胺酮/丙泊酚混合剂使心率有非显著性增加(加权平均差,每分钟3.36次搏动(95%CI,-0.88,7.60),I² = 88.6%),收缩压有统计学显著性增加(加权平均差,9.67 mmHg(95%CI,1.48,17.86),I² = 87.2%),舒张压有非显著性增加(加权平均差,2.18 mmHg(95%CI,-2.82,7.19),I² = 73.1%),平均动脉压有非显著性增加(加权平均差,3.28 mmHg(95%CI,-0.94,7.49),I² = 69.9%)。偏倚风险高,证据确定性低。总之,在接受气道操作且需要镇静的患者中,与非氯胺酮/丙泊酚镇静相比,使用氯胺酮/丙泊酚混合剂可能与更好的血流动力学相关。本试验已在CRD42019125725注册。